Vaxxinity, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vaxxinity, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q4 2023.
  • Vaxxinity, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $1.08M, a 54.1% decline year-over-year.
  • Vaxxinity, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $7.51M, a 13.8% decline year-over-year.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.51M, a 13.8% decline from 2022.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.71M, a 71.3% decline from 2021.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $30.4M, unchanged from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.